Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):438–441. doi: 10.1097/PAI.0b013e3181993d86

Table 4.

Number of cores with targeted area, per target diagnosis

Target lesion Total
cases
Number of cores with targeted area per case (%)
≥1 1 2 ≥3
Normal TDLUs 3611 275 (76.2) 93 (25.8) 96 (26.6) 86 (23.8)
UDH 1392 91 (65.5) 31 (22.3) 40 (28.8) 20 (14.4)
ADH 503 20 (40.0) 12 (24.0) 6 (12.0) 2 (4.0)
ALH 254 15 (60.0) 6 (24.0) 6 (24.0) 3 (12.0)
1

4 normal TDLUs targeted areas had 6 cores; all remaining women had 3 cores

2

11 UDH targeted areas had 6 cores; all remaining had 3 cores

3

5 ADH targeted areas had 6 cores; all remaining had 3 cores

4

3 ALH targeted areas had 6 cores; 1 ALH had 9 cores; all remaining had 3 cores

TDLUs=terminal duct lobular units, UDH=usual ductal hyperplasia, ADH=atypical ductal hyperplasia, ALH=atypical lobular hyperplasia